Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Italy Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20091
20121
20132
20141
20162
20174
20181
20193
20207
20211
20227
20238
20247
20255
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting18
Active, not recruiting10
Unknown status8
Terminated4
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
Insmed Incorporated3
Istituto Clinico Humanitas3
United Therapeutics3
Bristol-Myers Squibb2
GlaxoSmithKline2
Hoffmann-La Roche2
Actelion1
AllRock Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial61
Idiopathic Pulmonary Fibrosis12
Pulmonary Fibrosis7
Hypertension, Pulmonary6
Scleroderma, Systemic6
Scleroderma, Diffuse5
COVID-194
Connective Tissue Diseases4
Arthritis, Rheumatoid3
Autoimmune Diseases3

Trials

Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.